Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-85,000
Closed -$5.9M 68
2023
Q3
$5.9M Buy
+85,000
New +$6.42M 1.12% 33
2023
Q1
Sell
-105,400
Closed -$7.88M 122
2022
Q4
$7.88M Sell
105,400
-4,600
-4% -$328K 0.41% 64
2022
Q3
$7.1M Buy
+110,000
New +$7.62M 0.41% 65
2022
Q1
Sell
-75,000
Closed -$5.74M 250
2021
Q4
$5.74M Sell
75,000
-125,000
-63% -$9.19M 0.21% 107
2021
Q3
$14.8M Buy
200,000
+125,000
+167% +$9.37M 0.45% 57
2021
Q2
$5M Sell
75,000
-25,000
-25% -$1.67M 0.16% 117
2021
Q1
$7.44M Buy
100,000
+60,000
+150% +$4.56M 0.21% 98
2020
Q4
$2.91M Buy
+40,000
New +$2.82M 0.11% 129

Other funds holding HOLX

Pura Vida Investments's HOLX Position: Q4 2023 in Review

Pura Vida Investments sold out of Hologic (HOLX) in Q4 2023, closing a stake of 24,087 shares — an estimated $1.67M sold.

Pura Vida Investments first reported a position in HOLX in Q4 2016 and held it in 5 quarters. The position peaked at $10.7M in Q1 2017. 733 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • Pura Vida Investments reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • Pura Vida Investments sold 24,087 Hologic shares in Q4 2023, an estimated $1.67M.
  • Pura Vida Investments first reported a position in Hologic in Q4 2016 and held it in 5 quarters.
  • Pura Vida Investments's Hologic position peaked at $10.7M in Q1 2017.
  • 733 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Pura Vida Investments's 13F filing for Q4 2023, filed 13 Feb 2024.